Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study (vol 22, pg 85, 2021)

被引：0

作者：

Tan, A. R.

Im, S-A

Mattar, A.

机构：

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：E42 / E42

页数：1

共 1 条

Tan, Antoinette R. ;

Im, Seock-Ah ;

Mattar, Andre ;

Colomer, Ramon ;

Stroyakovskii, Daniil ;

Nowecki, Zbigniew ;

De laurentiis, Michelino ;

Pierga, Jean-Yves ;

Jung, Kyung Hae ;

Schem, Christian ;

Hogea, Alexandra ;

Crnjevic, Tanja Badovinac ;

Heeson, Sarah ;

Shivhare, Mahesh ;

Kirschbrown, Whitney P. ;

Restuccia, Eleonora ;

Jackisch, Christian .